CORMEDIX INC.

Company

CorMedix Inc.

Filed

August 10, 2020

Accession Number

0000902664-20-002925

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →